Ranbaxy gets FDA nod to sell generic Diovan tablets in US
June 27, 2014 18:22 ISTNew Delhi: Drug major Ranbaxy Laboratories has received the U.S. health regulator's approval to market a generic version of Novartis' Diovan tablets, used for treating high blood pressure and heart failure, in the U.S. with